Literature DB >> 9620107

Treatment of septic shock with immunotherapy.

A L Smith1.   

Abstract

Sepsis is the thirteenth leading cause of death in the United States. Despite increased knowledge about its pathophysiology, availability of powerful antibiotics, and advanced diagnostic and monitoring techniques, mortality rates have not changed significantly over the past 30 years. Immunotherapy may improve outcome in the critically ill with sepsis, although trial results have been disappointing to date.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620107

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  1 in total

1.  Pretreatment of mice with clindamycin improves survival of endotoxic shock by modulating the release of inflammatory cytokines.

Authors:  N Hirata; K Hiramatsu; K Kishi; T Yamasaki; T Ichimiya; M Nasu
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.